Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients

Trine Lembrecht Jørgensen, Sandra Teiblum, Merete Paludan, Laurids Østergaard Poulsen, Anni Young Stensgård Jørgensen, Karin Herskind Bruun, Jesper Hallas, Jørn Herrstedt

77 Citationer (Scopus)

Abstract

Age is associated with poor prognosis in ovarian cancer patients. Reasons could be increased comorbidity, more advanced stage, or nonoptimal surgery or chemotherapy. Objectives of this study were to evaluate the significance of comorbidity and age ≥70 years on receiving cytoreductive surgery, standard combination chemotherapy (TC), adherence to TC treatment, and prognosis.
OriginalsprogEngelsk
TidsskriftJournal of Gynecologic Oncology Nursing
Vol/bind127
Udgave nummer2
Sider (fra-til)367-74
Antal sider8
ISSN1536-9935
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients'. Sammen danner de et unikt fingeraftryk.

Citationsformater